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Abstract
Background: In Switzerland, 30% of HIV-infected individuals are diagnosed late. To optimize HIV testing, the Swiss
Federal Office of Public Health (FOPH) updated ‘Provider Induced Counseling and Testing’ (PICT) recommendations
in 2010. These permit doctors to test patients if HIV infection is suspected, without explicit consent or pre-test
counseling; patients should nonetheless be informed that testing will be performed. We examined awareness of
these updated recommendations among emergency department (ED) doctors.
Methods: We conducted a questionnaire-based survey among 167 ED doctors at five teaching hospitals in French-
Speaking Switzerland between 1st May and 31st July 2011. For 25 clinical scenarios, participants had to state whether
HIV testing was indicated or whether patient consent or pre-test counseling was required. We asked how many HIV
tests participants had requested in the previous month, and whether they were aware of the FOPH testing
recommendations.
Results: 144/167 doctors (88%) returned the questionnaire. Median postgraduate experience was 6.5 years
(interquartile range [IQR] 3; 12). Mean percentage of correct answers was 59 ± 11%, senior doctors scoring higher
(P=0.001). Lowest-scoring questions pertained to acute HIV infection and scenarios where patient consent was not
required. Median number of test requests was 1 (IQR 0-2, range 0-10). Only 26/144 (18%) of participants were aware
of the updated FOPH recommendations. Those aware had higher scores (P=0.001) but did not perform more HIV
tests.
Conclusions: Swiss ED doctors are not aware of the national HIV testing recommendations and rarely perform HIV
tests. Improved recommendation dissemination and adherence is required if ED doctors are to contribute to earlier
HIV diagnoses.
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Introduction
It is now well-recognized that late diagnosis of HIV in
infected individuals is associated with an avoidable burden of
morbidity [1], mortality and cost [2]. In spite of this, in
Switzerland, 30% of individuals newly diagnosed with HIV are
diagnosed late, that is, with CD4 counts <200 cells/microlitre
[1]. HIV prevalence in Switzerland is 0.4% [3], above the
threshold of 0.1% set by the 2006 Centers of Disease Control
and Prevention (CDC) recommendations for proposing opt-out
testing [4].
In March 2010, the Swiss Federal Office of Public Health
(FOPH) updated the 2007 HIV testing recommendations
proposing ‘Provider Induced Counseling and Testing’ (PICT) [5]
(also known as ‘Physician-Initiated Counseling and Testing’).
These recommendations implicitly propose diagnostic testing
and targeted screening rather than opt-out testing but, like the
CDC recommendations, they decouple testing from pre-test
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counseling and consent, whilst maintaining a need to inform
the patient when HIV testing is indicated. They place the duty
of testing on the doctor and emphasize the importance of
recognizing four scenarios: 1) symptoms and signs of acute
HIV infection (AHI); 2) those of advanced HIV infection; 3)
settings in which HIV screening is indicated; and 4) patients at
high risk of HIV infection. These scenarios are detailed further
both in the text and in the form of five sets of lists (Table S1,
S2a, S2b, S2c and S3). For patients presenting symptoms and
signs of HIV infection, or in settings in which HIV screening is
indicated, the revised recommendations state that ‘the doctor
should inform the patient that an HIV test is indicated’ and that
the patient has to state explicitly that s/he refuses to be tested
for the test not to be performed. For patients considered at risk
of HIV infection, through high risk activities or their socio-
demographic profiles, the doctor should perform pre-test
counseling and the patient must give explicit verbal consent for
the test to be performed. Although the symptoms, signs and
pathologies in which HIV testing is indicated are clearly listed,
the difference between informing a patient that an HIV test is
indicated and suggesting an HIV test after pre-test counseling
might be considered as subtle.
We recently reported that the new FOPH recommendations
made no difference to testing practices in nine clinical services
in our centre and observed that, of the tens of thousands of
patients seen in our emergency department (ED) annually, only
1% are tested for HIV [6]. In the present study, as a first step in
determining why ED testing rates are so low, we set out to




The study was approved by the ethics committee on human
scientific research of the canton of Vaud, Switzerland (14th
February 2011). All participants (see below) provided informed
written consent prior to taking part in the study.
Setting and participants
The study took place in the EDs of the five principal hospitals
in French-speaking Switzerland: two university hospitals
(Lausanne University Hospital and the Hôpitaux Universitaires
de Genève) and three cantonal (university-affiliated) hospitals
(Hôpitaux Neuchâtelois, the Hôpital de Sion, and the Hôpital
Fribourgeois). Between them, the EDs in these hospitals
receive over 175,000 patient visits per year (Table S4). All ED
doctors of Resident, Chief Resident and Attending grades were
invited to participate in the study. No specific training on HIV
testing was organized for medical staff prior to the study so as
to be representative of the ‘real life’ situation. However, all
junior doctors have received training on this subject as part of
their undergraduate studies (MC, personal communication).
Because we aimed to target only healthcare professionals who
are directly responsible for requesting HIV tests, medical
students and non-medical ED staff, who do not have this
responsibility, were excluded.
It should be noted that, in Switzerland, emergency medicine
is accredited as a sub-specialty rather than a full specialty and
so there is no formal national training curriculum. Training
received by junior doctors in the ED is determined by the areas
of expertise of their supervising colleagues and by the clinical
competencies perceived to be required in the specific ED [7].
Study design
The survey took place between 1st May and 31st July 2011.
ED doctors were asked to complete the questionnaire (see
below) during scheduled departmental seminar times
organized by each ED head. The estimated time to complete
the questionnaire was 20 minutes and we aimed for a minimum
participation of 65%. The ED heads were also requested to
provide figures for patient turnover in 2010 and the number of
doctors practicing in their departments. Completed
questionnaires were returned to the Lausanne centre for
incorporation into an anonymized database.
Questionnaire (Text S1 and Table 1)
As all participants were French-speaking, the study
questionnaire was written and completed in French. An English
translation is supplied as Text S1. The questionnaire consisted
of a front page and three sections of questions. The front page
covered participant demographics, including place of work,
postgraduate experience (in years) and grade (options:
‘Resident’, ‘Chief Resident’ and ‘Attending’). The first section of
questions (Section 1) contained 12 clinical scenarios describing
symptoms and/or pathologies based on the lists provided in the
FOPH recommendations. For each scenario, participants had
to state a) whether or not HIV testing was indicated according
to the FOPH recommendations (options: ‘yes’ and ‘no’) and b)
the probability with which they would perform an HIV test in
their own clinical practice (options: 0-25%, 26-50%, 51-75%
and 76-100%). A disparity was said to occur if we observed a
mismatch between testing indication awareness and clinical
practice, that is, if a participant answered correctly that an HIV
test was indicated but stated the probability of performing a test
in practice at 0-25% or, conversely, that an HIV test was not
indicated but stated the probability of performing a test in
practice at 75-100%. The second section (Section 2) contained
seven questions requiring the participants to identify the correct
method of testing, either informing patients that HIV testing was
indicated or performing pre-test counseling, and six questions
requiring participants to identify the serological tests with which
HIV testing should be performed routinely. As for Section 1, all
questions in Section 2 were derived from the FOPH
recommendations. Each question in Sections 1 and 2 was
assigned one point if answered correctly and scores were
presented as a percentage of the maximum possible score: 12
points for Section 1; seven points for the consent part of
Section 2; six points for the serology part of Sections 2, and 25
points in total.
The final section of the questionnaire asked how many HIV
tests participants had performed in the preceding four weeks
and whether or not they were aware of the updated FOPH
recommendations. If aware, they were invited to state the
source (options: clinical seminar, on line search, FOPH
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recommendations, a specific article on HIV testing published in
a national journal: the Swiss Medical Forum, or ‘other’ means).
Prior to this study, the questionnaire was pilot-tested on five
senior doctors working in acute medicine at a clinic not
included in our study. The purpose of this pilot was two-fold: 1)
to ensure the questions were fully comprehensible and without
ambiguity and 2) to determine the time required to complete
the questionnaire. As the five doctors completed all sections
correctly and reported no ambiguity, the questionnaire was
used for the study without further validation.
Statistical analyses
Data are presented as means with standard deviation (SD),
medians with interquartile range (IQR), or percentages.
Proportions were compared in two-way contingency table
analyses using Chi squared tests and means were compared
using Student’s t test. Non-parametric data were analyzed
using the Mann Whitney U test. All statistical analyses were
performed using STATA™ software version 12 for Windows
(StataCorp, College Station, Texas) and Microsoft Excel 2008
(Microsoft Corporation, Redmond, WA, USA).
Results
Participant characteristics
Of 164 ED doctors invited to participate in the study, 144/164
(88%) completed the questionnaire. Response rate was >65%
in all but one centre (where response rate was 43%, Table S4).
Of the 144 participants, 75/144 (52%) were male, 25/144 (17%)
were Attendings and 100/144 (69%) worked at university (as
opposed to cantonal) hospitals. Mean age was 35 +/- 6 years
and median postgraduate experience was 6.5 years (IQR 3;
12).
Questionnaire responses (Tables 1, 2 and S4)
Questionnaire scores (the percentage of correct responses)
were examined according to clinical scenario (Table 1), doctor
grade (Table 2) and ED (Table S4). In Section 1, the mean
score for all participants was 66 ± 14%. Participants scored
better for clinical scenarios in which HIV testing was not
indicated than for those in which testing was indicated (88% ±
13% versus 59% ± 15%, P=0.04). The lowest scoring question
in this section was question 2 (correct response rate of 26%,
Table 1), which pertained to AHI.
We observed some disparity between participants’
awareness that HIV testing was indicated and their stated
probability of performing a test in clinical practice. Disparity was
more frequently observed among low-scoring questions. Of the
three questions with a correct response rate of ≤50%
(questions 1, 2 and 6, Table 1), 14-17% of the participants who
did respond correctly that HIV testing was indicated stated a
probability of 0-25% of performing a test in clinical practice.
The majority (75-83%) of participants displaying this disparity
were of senior grade (Chief Residents and Attendings as
opposed to Residents, P=0.02). The only other question with a
disparity rate of >10% but with a correct response rate >50%
was scenario 12, a patient presenting with symptoms of
pregnancy: of 60% of participants who answered correctly that
HIV testing was indicated, 14% stated a 0-25% probability of
conducting a test in clinical practice. Conversely, for questions
in which doctors stated the guidelines did not recommend
testing, no participant stated s/he would perform a test with a
high probability (75-100%).
In Section 2, the mean score was 40 ± 16% for the consent
questions and 69 ± 18% for the serology questions. Consent-
based questions had the worst scores in this section,
particularly those pertaining to the lack of requirement for pre-
test counseling when HIV infection was suspected (Table 1).
Considering doctor grade, senior doctors (Chief Residents
and Attendings) had a higher mean score than juniors
(Residents) for Section 1 (70 ± 14% versus 63 ± 15%,
P=0.013), Sections 1 and 2 together (64 ± 10% versus 56 ±
11%, P=0.001) and the serology part of Section 2 (74 ± 16%
versus 66 ± 19%, P=0.03) but not significantly so for the
consent part of Section 2 (43 ± 15% versus 37 ± 16%, P=0.07).
Examining hospital type, there was no significant difference
between the scores of university hospitals compared to non-
university hospitals: 66 ± 14% versus 67± 15%, (P=0.71) for
Section 1, but there was a difference for Section 2, for both
parts: consent (34 ± 15% versus 42 ± 16%, P=0.03) and
serology (62 ± 19% versus 72 ± 18%, P=0.009).
Awareness of the FOPH HIV testing guidelines
Twenty-six participants out of 144 (18%) were aware of the
new recommendations. Recommendation awareness was
lower among junior doctors (Residents) than seniors (Chief
Residents and Attendings) (Table 2, P=0.02). Considering
hospital type, although none of the doctors in two of the three
cantonal hospitals were aware of the recommendations (Table
S4), there was no significant difference in doctor awareness
between university and non-university hospitals (P=0.49). For
doctors who were aware of the recommendations, the principal
means of awareness were through reading an article on testing
in the Swiss Medical Forum (10/26, 39%) and attending clinical
seminars (9/26, 35%). Only 4/26 (15%, or 2.8% [4/144] of all
participants) were aware through reading the original March
2010 FOPH bulletin. Doctors aware of the recommendations
had a higher total questionnaire score (67 ± 11% versus 58 ±
11%, P=0.001) and a higher score for questionnaire Section 1
(76 ± 9.7% versus 64 ± 14%, P=0.001). Examining the
questions in Section 2 regarding patient consent (which had
the lowest mean score), doctors who were aware of the FOPH
guidelines scored better than those unaware: 50 ± 18% versus
37 ± 16% (P=0.004); there was no significant difference in
scores for questions regarding serology (71 ± 16% versus 69 ±
18%, P=0.6).
HIV testing practices
Despite higher questionnaire scores among doctors aware of
the testing recommendations, being aware did not influence the
number of tests performed during the preceding four weeks
(mean 1.5 versus 1.4, P=0.55 or median 1 [IQR 0; 2, range
1-10] in both groups, P=0.54). Although senior doctors tested
slightly more than junior grades, this difference was not
significant (P=0.2). There was no difference in test request
Awareness of HIV Testing Guidelines
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numbers between university and non-university hospitals
(P=0.8).
Discussion
We observe that awareness of the updated national HIV
testing recommendations among ED doctors in the five
principal hospitals in French-speaking Switzerland is low
(18%). Doctors aware of the recommendations had higher
questionnaire scores for recognizing when HIV testing was
indicated (Section 1) and whether or not consent was required
(Section 2) but did not perform more tests than those unaware.
Finally, we observe important disparities between
recommendation awareness and application.
Low awareness of HIV testing recommendations among
health professionals has been described. In a questionnaire-
based study conducted in San Francisco, Cohan et al.
observed that 44/224 non-primary care providers (24%), from
departments including internal medicine, surgery, obstetrics/
gynecology and emergency medicine, were aware of the 2006
CDC HIV testing recommendations [8]. Whilst it is reassuring to
observe in our study that doctors who were aware of national
recommendations were better at identifying the clinical settings
in which HIV testing is indicated, the lack of awareness in our
EDs is a problem.
Between them, the EDs we studied receive over 175,000
patient visits annually. A proportion of these patients use the
ED as a source of primary healthcare, particularly individuals
from vulnerable populations who have suboptimal access to
healthcare and yet may be at high risk of HIV infection [9]. If we
assume that all patients attending the EDs we studied are
representative of the wider Swiss population, in which HIV
Table 1. Clinical scenarios in Sections 1 and 2 of the study questionnaire, whether HIV testing is indicated according to the
2010 Swiss Federal Office of Public Health recommendations, number (percentage) of correct responses for each question
and number (percentage) of questions with disparity, as defined in Methods.
Question Clinical scenario Correct response Correct responders, n (%)Disparity, n (%)
Section 1  
 Is HIV testing indicated in the following situations, according to national recommendations:
1 Acute peripheral facial nerve palsy Yes 72 (50) 12/72 (17)
2 3-day history of sore throat, fever, submandibular lymphadenopathy; no cough Yes 37 (26) 5/37 (14)
3 Fever, headache, meningeal signs; Gram negative diplococci on CSFexamination No 98 (68) 0/98 (0)
4 3-month history of unintentional weight loss, diarrhea and intermittent fever Yes 111 (77) 4/111 (3.6)
5 Urosepsis in elderly woman with indwelling catheter No 140 (97) 0/140 (0)
6 Several-month history of general fatigue Yes 48 (33) 8/48 (17)
7 Fractured wrist post-trauma No 140 (97) 0/140 (0)
8 Aseptic meningitis in subfebrile patient Yes 110 (76) 8/110 (7.3)
9 Male with dysuria and meatal erythema with no relevant sexual history Yes 101 (70) 5/101 (5)
10 Acute rash and low-grade fever in patient immune to measles Yes 92 (64) 9/92 (9.8)
11 Herpes zoster in young patient Yes 105 (73) 9/105 (8.6)
12 Diagnosis of pregnancy in patient presenting with vomiting Yes 87 (60) 12/87 (14)
Section 2  
 Can physicians inform patients that HIV test will be performed or must explicit consent be sought: (multiple choice)
13 Married man presenting with features of seroconversion illness Patient should be informed thattest will be performed 35 (24)  
14 HIV suspected as causal diagnosis  21 (15)  
 Is pre-test counseling indicated in the following settings:
15 Patient wishing to be tested for HIV Yes 123 (85)  
16 Patient discloses he is homosexual Yes 78 (54)  
17 Clinical features of acute HIV infection No 37 (26)  
18 Patient with Kaposi’s sarcoma No 49 (34)  
19 Patient from sub-Saharan Africa Yes 57 (40)  
 Should an HIV test be added automatically when screening for the followingconditions:    
20 Hepatitis B Yes 125 (87)  
21 Hepatitis A No 124 (86)  
22 Lyme disease for unexplained atrio-ventricular block No 117 (81)  
23 Epstein-Barr virus Yes 75 (52)  
24 Cytomegalovirus Yes 83 (58)  
25 Causes of unexplained rash with fever Yes 75 (52)  
doi: 10.1371/journal.pone.0072812.t001
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seroprevalence is 0.4% [3], then, among the patients
presenting to these centers, we would expect 525-700 to be
HIV positive (based on Lausanne ED figures, up to 25% of
patients present more than once per annum [OH, personal
communication]). Using our figures for patient visits per annum
(Table S4), we can estimate the HIV testing rate in the EDs we
studied (=[tests performed / patients seen] x 100 [6]) by
extrapolating the median number of tests performed per doctor
per month (=1 test) to the number performed in one year (=1 x
12), and then multiplying by the number of practicing ED
doctors. Based on our data in Table S4, the estimated testing
rate is 1.1-1.5%. As many HIV tests need to be performed for
one new HIV diagnosis, even with physician-directed
diagnostic HIV testing [10], our estimated testing rate indicates
that EDs in this part of Switzerland are missing undiagnosed
HIV infection.
Whilst large studies using rapid HIV tests for non-targeted
(opt-out) screening in the ED have shown only modest
increases in HIV diagnoses, and often at late stages in the
disease [10,11], and whilst the most appropriate model for HIV
testing in the ED has yet to be formulated [12,13], a knowledge
among ED doctors of the clinical scenarios in which HIV testing
is indicated is an important first step. AHI, for example, remains
a diagnosis often missed [14,15], whilst being a stage of
infection during which the risk of onward HIV transmission is
high [16]. The FOPH recommendations clearly set out a list of
symptoms and signs of AHI and other HIV-associated
pathology and the lack of awareness of these presents a
barrier to the diagnostic testing and targeted screening
proposed. That said, even if clinicians are aware of these
recommendations and apply the testing recommendations
perfectly, the targeted approach that the FOPH recommended
would fail to identify the majority of undiagnosed HIV infected
patients who present to the ED with clinical conditions
unrelated to HIV [17,18]. Finally, our observation that senior
doctors are aware of the clinical settings in which HIV testing is
indicated and yet admit that they would not test in clinical
practice deserves further exploration.
Our observations have individual- and public health-level
implications. At the individual level, patients who present
symptoms and signs which should trigger HIV testing may go
untested and ultimately experience the consequences of late
diagnosis. At the public health level, missed HIV diagnoses
contribute to the risk of onward transmission and indeed to the
epidemic itself. For public health professionals, our results
suggest a problem with guideline dissemination: of all
participants, <3% were aware of the recommendations by way
of the original FOPH publication. Finally, if doctors who have
read the recommendations do not understand when HIV should
be added routinely to other serological tests and do not test the
patients they encounter in whom HIV testing is indicated, there
are implications regarding not only awareness of
recommendations but also agreement and adherence [19].
How can our observations shape clinical practice and health
care delivery? Whilst we did not explore the reasons for not
testing among our participants (see limitations, below), several
barriers to testing in the ED have been cited in other studies.
These include internal barriers, such as doctors not perceiving
patients to be at risk for HIV infection [20] or not believing that
HIV testing is part of their professional remit [21], and external
barriers such as cost, lack of time and lack of resources for
delivering ‘routine’, as opposed to emergency, care [21] or
difficulty in providing follow up care when on-site tests are not
available [22]. Our results suggest that potential barriers vary
Table 2. Results presented according to emergency department doctors participating in the study: participant characteristics,
questionnaire scores (percentage of correct responses), number of HIV tests requested by participants, and awareness of
national HIV testing recommendations.
Characteristic Resident (n = 83) Chief Resident (n = 36) Attending (n = 25) All doctors (n = 144)
Age, years, mean (SD) 30.1 (2.4) 37.4 (3.9) 47.6 (5.8) 35 (6.3)
Postgraduate experience, years, median (IQR) 3 (2;5) 10.1 (8;13) 18.9 (14;23) 6.5 (3;12)
University hospital based, n (%) 57 (69) 27 (75) 16 (64) 100 (69)
Questionnaire score (% correct responses):     
Section 1 : scenarios, mean (SD) 63 (15) 71 (16) 69 (11) 66 (14)
Section 2 : consent, mean (SD) 37 (16) 41 (14) 47 (17) 40 (16)
Section 2 : serology, mean (SD) 66 (19) 76 (16) 70 (16) 69 (18)
Total (Sections 1+2), mean (SD) 56 (11) 64 (11) 63 (9.3) 59 (11)
Participants stating probability of 0-25% of requesting HIV test even if
indicated, n (%) 17 (21) 14 (39) 8 (32) 39 (27)
No. of tests in past month, median (IQR) 0 (0;2) 1(0;2.3) 0 (0;2) 1 (0;2)
Aware of recommendations, n (%) 7 (8.4) 8 (22) 11 (44) 26 (18)
Abbreviations: IQR, interquartile range; SD, standard deviation
doi: 10.1371/journal.pone.0072812.t002
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according to the stage of clinical training. For junior doctors
who are less aware of testing recommendations than their
seniors, universal training in HIV testing in the ED would be
beneficial. As ED doctors in Switzerland have a variety of
specialist backgrounds, this would allow one aspect of ED
training to be unified. For senior doctors, internal barriers could
also be addressed in training sessions. Many external barriers
to testing could be addressed by simplifying the testing
process: by decoupling pre-test counseling from testing for all
patients, by verbally informing patients that testing will be
performed as part of the diagnostic procedure, and by making
available on-site (rapid) testing to optimize continuity of care
when issuing the test result. These latter measures are not
restricted to Switzerland but are applicable elsewhere: the fine
points of national testing recommendations become irrelevant if
clinicians perceive barriers – real or imagined – to their
application.
This study has limitations. We did not ask participants what
training they had received on HIV testing or about their
subjective level of competence in this area. For the doctors
who identified that HIV testing was indicated but stated a low
probability that they would perform a test, we did not ask about
perceived barriers to testing. We also did not compare reported
testing rates with actual rates, although the low figures
obtained from the questionnaire agree with our previous study
in one of the five centers [6]. Finally, we did not ask about the
methods of HIV testing in each centre, specifically, whether any
participants use point-of-care rapid testing and whether this
influenced the number of tests requested. As described above,
these unexplored areas will form the basis of future studies.
In summary, Swiss ED doctors are not aware of the updated
national HIV testing recommendations, do not adhere to its
content, and rarely perform HIV tests. Improved dissemination
of these recommendations is required if ED doctors are
expected to play a significant role in reducing the burden of
undiagnosed HIV infection. Furthermore, the identification and
tackling of barriers to HIV testing among doctors who recognize
when such testing is indicated represents an important parallel
step.
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